Themis Medicare Ltd (THEMISMED) โ FY26 Annual Report | 8 September 2026
Themis Medicare reported a consolidated net loss of [amount context mismatch] lakhs for FY2026, with total revenue at [amount context mismatch] lakhs, while its associates generated โน27,970.52 lakhs in revenue and โน5,671.45 lakhs in net profit, reflecting strong underlying performance despite the parent's loss. The company maintains unmodified audit opinions on financial statements, internal controls, and compliance with Ind AS and regulatory norms, including effective audit trails and no director disqualifications. Governance structures remain robust, with active committees and timely disclosures, and no deposits or deemed deposits were accepted during the year.
About Themis Medicare Ltd (THEMISMED)
Healthcare ยท Pharmaceuticals ยท Listed on BSE
๐ก Get AI alerts when THEMISMED files next
Free โข Daily 5 PM digest โข Track filings, board meetings, and corporate actions
Track THEMISMED โ Free๐ก Ask AI about this filing
๐ More THEMISMED filings
- ๐ด Corporate Action โ 24 September 2026Themis Medicare Limited withdrew its proposed preferential issue of 4,595,795 convertible warrants p...
- Announcement โ 23 September 2026Themis Medicare Limited announced that its trading window will close on 1 October 2026 due to SEBI i...
- ๐ด Corporate Action โ 18 September 2026Themis Medicare announced a record date of September 23, 2026, for final dividend entitlement for FY...
- Announcement โ 17 August 2026Themis Medicare Limited updated its official email addresses for corporate correspondence and regist...
- ๐ก Board Meeting โ 13 August 2026Themis Medicare announced the outcome of its board meeting held on 13 August 2026, where it approved...
๐ฅ Also filed on 8 September 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only โ not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
๐ก Get AI alerts when THEMISMED files new disclosures
Track THEMISMED filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track THEMISMED โ FreeFree account ยท 2 AI queries/day